(BLX) Boralex - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA09950M3003

BLX: Electricity, Wind, Solar, Hydroelectric Power

Boralex Inc. is a seasoned player in the renewable energy space, with a footprint spanning Canada, France, the United States, and the United Kingdom. The company specializes in the development, construction, and operation of power facilities that harness wind, solar, and hydroelectric resources. As of December 31, 2023, Boralex operates an extensive portfolio of 100 wind farms, 12 solar energy facilities, 15 hydroelectric power stations, and 2 storage units. This infrastructure translates to an installed capacity of 1,819 megawatts (MW) in North America and 1,259 MW in Europe, underscoring its balanced geographic diversification.

Founded in 1982 and headquartered in Kingsey Falls, Canada, Boralex has built a reputation for its operational expertise and strategic growth. The company’s market capitalization stands at 2,655.47 million CAD, reflecting its established presence in the renewable energy sector. From a valuation perspective, Boralex trades at a trailing P/E of 30.05 and a forward P/E of 24.81, suggesting that investors are pricing in expectations of future growth. The price-to-book ratio of 1.60 indicates that the market values the company’s assets at a modest premium to their book value. Additionally, the price-to-sales ratio of 2.77 provides insight into how investors view the company’s revenue generation relative to its market value.

For investors and fund managers, Boralex’s diversified portfolio of renewable energy assets offers a compelling mix of stability and growth potential. The company’s presence across multiple jurisdictions and energy sources reduces reliance on any single market or technology, which can mitigate risk. Furthermore, its existing storage capabilities and development pipeline position it well to capitalize on the increasing demand for renewable energy and grid resilience. As the global energy landscape continues to shift toward decarbonization and sustainability, Boralex is strategically positioned to benefit from these macro trends. More information about the company can be found at https://www.boralex.com.

Additional Sources for BLX Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

BLX Stock Overview

Market Cap in USD 2,107m
Sector Utilities
Industry Utilities - Renewable
GiC Sub-Industry Renewable Electricity
IPO / Inception

BLX Stock Ratings

Growth 5y 17.8%
Fundamental -19.8%
Dividend 59.5%
Rel. Strength Industry -12.6
Analysts -
Fair Price Momentum 28.85 CAD
Fair Price DCF -

BLX Dividends

Dividend Yield 12m 7.32%
Yield on Cost 5y 11.94%
Annual Growth 5y 8.11%
Payout Consistency 37.8%

BLX Growth Ratios

Growth Correlation 3m -4.4%
Growth Correlation 12m -7.8%
Growth Correlation 5y 6.3%
CAGR 5y 9.74%
CAGR/Max DD 5y 0.20
Sharpe Ratio 12m 0.53
Alpha 2.61
Beta 0.49
Volatility 28.14%
Current Volume 330.5k
Average Volume 20d 389.4k
What is the price of BLX stocks?
As of March 15, 2025, the stock is trading at CAD 29.06 with a total of 330,481 shares traded.
Over the past week, the price has changed by +0.03%, over one month by +14.30%, over three months by +0.82% and over the past year by +9.21%.
Is Boralex a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Boralex is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -19.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BLX as of March 2025 is 28.85. This means that BLX is currently overvalued and has a potential downside of -0.72%.
Is BLX a buy, sell or hold?
Boralex has no consensus analysts rating.
What are the forecast for BLX stock price target?
According to ValueRays Forecast Model, BLX Boralex will be worth about 31.2 in March 2026. The stock is currently trading at 29.06. This means that the stock has a potential upside of +7.23%.
Issuer Forecast Upside
Wallstreet Target Price 38.6 32.7%
Analysts Target Price - -
ValueRay Target Price 31.2 7.2%